Sangamo Biosciences, Inc. (SGMO) Posts Q1 Loss of 14c/Share

Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q1 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.2 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat